TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Swedish Orphan Biovitrum AB (publ)
Closing information (x1000 DKK)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
12,556,103
|
11,291,623
|
11,310,853 |
| Financial expenses |
332,112
|
330,118
|
446,179 |
| Earnings before taxes |
2,219,203
|
2,395,898
|
3,125,474 |
| EBITDA |
4,067,536
|
4,168,644
|
5,070,280 |
| Total assets |
35,079,572
|
35,382,941
|
35,785,460 |
| Current assets |
7,491,563
|
6,382,759
|
6,053,800 |
| Current liabilities |
9,927,941
|
6,370,398
|
7,739,941 |
| Equity capital |
17,724,887
|
16,871,630
|
14,975,892 |
| - share capital |
113,600
|
122,885
|
123,774 |
| Employees (average) |
1,556
|
1,559
|
1,509 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
50.5%
|
47.7%
|
41.8% |
| Turnover per employee |
8,069
|
7,243
|
7,496 |
| Profit as a percentage of turnover |
17.7%
|
21.2%
|
27.6% |
| Return on assets (ROA) |
7.3%
|
7.7%
|
10.0% |
| Current ratio |
75.5%
|
100.2%
|
78.2% |
| Return on equity (ROE) |
12.5%
|
14.2%
|
20.9% |
| Change turnover |
2,179,109
|
194,871
|
750,796 |
| Change turnover % |
21%
|
2%
|
7% |
| Chg. No. of employees |
-3
|
50
|
174 |
| Chg. No. of employees % |
0%
|
3%
|
13% |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.